These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 30707922)

  • 21. Immunological responses and protective efficacy against Brucella melitensis induced by bp26 and omp31 B. melitensis Rev.1 deletion mutants in sheep.
    Jacques I; Verger JM; Laroucau K; Grayon M; Vizcaino N; Peix A; Cortade F; Carreras F; Guilloteau LA
    Vaccine; 2007 Jan; 25(5):794-805. PubMed ID: 17070627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the efficacy of outer membrane protein 31 vaccine formulations for protection against Brucella canis in BALB/c mice.
    Clausse M; Díaz AG; Ibañez AE; Cassataro J; Giambartolomei GH; Estein SM
    Clin Vaccine Immunol; 2014 Dec; 21(12):1689-94. PubMed ID: 25339409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of bp26 and bp26/omp31 B. melitensis Rev.1 deletion mutants against Brucella ovis in rams.
    Grilló MJ; Marín CM; Barberán M; de Miguel MJ; Laroucau K; Jacques I; Blasco JM
    Vaccine; 2009 Jan; 27(2):187-91. PubMed ID: 19007836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mannosylated chitosan nanoparticles loaded with FliC antigen as a novel vaccine candidate against Brucella melitensis and Brucella abortus infection.
    Sadeghi Z; Fasihi-Ramandi M; Azizi M; Bouzari S
    J Biotechnol; 2020 Feb; 310():89-96. PubMed ID: 32017955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of novel Omp31 antigenic epitopes of Brucella melitensis by monoclonal antibodies.
    Li J; Hu F; Chen S; Luo P; He Z; Wang W; Allain JP; Li C
    BMC Microbiol; 2017 May; 17(1):115. PubMed ID: 28506316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Invasive Escherichia coli vaccines expressing Brucella melitensis outer membrane proteins 31 or 16 or periplasmic protein BP26 confer protection in mice challenged with B. melitensis.
    Gupta VK; Radhakrishnan G; Harms J; Splitter G
    Vaccine; 2012 Jun; 30(27):4017-22. PubMed ID: 22546330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the protective immunity elicited by a Brucella cocktail protein vaccine (rL7/L12+rTOmp31+rSOmp2b) in two different adjuvant formulations in BALB/c mice.
    Golshani M; Amani M; Siadat SD; Nejati-Moheimani M; Arsang A; Bouzari S
    Mol Immunol; 2018 Nov; 103():306-311. PubMed ID: 30343119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanoparticle-Based Vaccines for Brucellosis: Calcium Phosphate Nanoparticles-Adsorbed Antigens Induce Cross Protective Response in Mice.
    Sadeghi Z; Fasihi-Ramandi M; Bouzari S
    Int J Nanomedicine; 2020; 15():3877-3886. PubMed ID: 32581535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A DNA vaccine coding for the chimera BLSOmp31 induced a better degree of protection against B. ovis and a similar degree of protection against B. melitensis than Rev.1 vaccination.
    Cassataro J; Pasquevich KA; Estein SM; Laplagne DA; Zwerdling A; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH; Goldbaum FA
    Vaccine; 2007 Aug; 25(32):5958-67. PubMed ID: 17600596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of immune responses induced by polymeric OMP25-BLS Brucella antigen.
    Yousefi S; Abbassi-Daloii T; Sekhavati MH; Tahmoorespur M
    Microb Pathog; 2018 Feb; 115():50-56. PubMed ID: 29253594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel recombinant multi-epitope protein against Brucella melitensis infection.
    Yin D; Li L; Song D; Liu Y; Ju W; Song X; Wang J; Pang B; Xu K; Li J
    Immunol Lett; 2016 Jul; 175():1-7. PubMed ID: 27133932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraperitoneal immunization with Urease loaded N-trimethyl Chitosan nanoparticles elicits high protection against Brucella melitensis and Brucella abortus infections.
    Abkar M; Fasihi-Ramandi M; Kooshki H; Lotfi AS
    Immunol Lett; 2018 Jul; 199():53-60. PubMed ID: 29548705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunization of mice with a novel recombinant molecular chaperon confers protection against Brucella melitensis infection.
    Ghasemi A; Jeddi-Tehrani M; Mautner J; Salari MH; Zarnani AH
    Vaccine; 2014 Nov; 32(49):6659-66. PubMed ID: 25240754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved immunogenicity and protective efficacy of a divalent DNA vaccine encoding Brucella L7/L12-truncated Omp31 fusion protein by a DNA priming and protein boosting regimen.
    Golshani M; Rafati S; Siadat SD; Nejati-Moheimani M; Shahcheraghi F; Arsang A; Bouzari S
    Mol Immunol; 2015 Aug; 66(2):384-91. PubMed ID: 25968974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brucella species lacking the major outer membrane protein Omp25 are attenuated in mice and protect against Brucella melitensis and Brucella ovis.
    Edmonds MD; Cloeckaert A; Elzer PH
    Vet Microbiol; 2002 Sep; 88(3):205-21. PubMed ID: 12151196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Immunogenicity of OMP31 Peptides and Its Protection Against Brucella melitensis Infection in Mice.
    Zhang F; Li Z; Jia B; Zhu Y; Pang P; Zhang C; Ding J
    Sci Rep; 2019 Mar; 9(1):3512. PubMed ID: 30837598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of humoral and cellular immune responses to BP26 and OMP31 epitopes in the attenuated Brucella melitensis vaccinated sheep.
    Wang W; Wu J; Qiao J; Weng Y; Zhang H; Liao Q; Qiu J; Chen C; Allain JP; Li C
    Vaccine; 2014 Feb; 32(7):825-33. PubMed ID: 24370708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of specific cell-mediated immune responses and protection in BALB/c mice by vaccination with outer membrane vesicles from a Brucella melitensis human isolate.
    Bagheri Nejad R; Yahyaraeyat R; Es-Haghi A; Nayeri Fasaei B; Zahraei Salehi T
    APMIS; 2019 Dec; 127(12):797-804. PubMed ID: 31514254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunization of mice with chimeric protein-loaded aluminum hydroxide and selenium nanoparticles induces reduction of
    Goudarzi T; Abkar M; Zamanzadeh Z; Fasihi-Ramandi M
    Clin Exp Vaccine Res; 2023 Oct; 12(4):304-312. PubMed ID: 38025913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The candidate vaccine strain Brucella ovis ∆abcBA is protective against Brucella melitensis infection in mice.
    Costa LF; Cabello AL; Batista DFA; Chaki SP; de Figueiredo P; da Paixão TA; Rice-Ficht AC; Ficht TA; Santos RL
    Microbiol Immunol; 2020 Nov; 64(11):730-736. PubMed ID: 32965738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.